NASDAQ : ANGO
AngioDynamics, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 11.99 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 504.23M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 504.23M |
| Enterprise Value | 481.00M |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 8, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 42.05M |
| Shares Outstanding | 42.05M |
| Shares Change (YoY) | +1.84% |
| Shares Change (QoQ) | +0.78% |
| Owned by Insiders (%) | 9.60% |
| Owned by Institutions (%) | 79.53% |
| Float | 32.76M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.55 |
| Forward PS | 1.48 |
| PB Ratio | 3.10 |
| P/TBV Ratio | 4.94 |
| P/FCF Ratio | 349.19 |
| P/OCF Ratio | 137.28 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.48 |
| EV / EBITDA | 366.34 |
| EV / EBIT | n/a |
| EV / FCF | 333.10 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.40 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 3.00 |
| Debt / FCF | 7.44 |
| Interest Coverage | -54.54 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -19.21% |
| Return on Assets (ROA) | -5.14% |
| Return on Invested Capital (ROIC) | -15.55% |
| Return on Capital Employed (ROCE) | -11.46% |
| Weighted Average Cost of Capital (WACC) | 5.73% |
| Revenue Per Employee | $514,839 |
| Profits Per Employee | -$52,114 |
| Employee Count | 632 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 2.48 |
Taxes
| Measure | Value |
|---|
| Income Tax | 178,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -1.07% |
| 50-Day Moving Average | 14.18 |
| 200-Day Moving Average | 12.48 |
| Relative Strength Index (RSI) | 39.40 |
| Average Volume (20 Days) | 1,026,852 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.92M |
| Short Previous Month | 1.29M |
| Short % of Shares Out | 4.56% |
| Short % of Float | 5.85% |
| Short Ratio (days to cover) | 2.02 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 325.38M |
| Gross Profit | 179.88M |
| Operating Income | -20.89M |
| Pretax Income | -32.76M |
| Net Income | -32.94M |
| EBITDA | 1.31M |
| EBIT | -20.89M |
| Loss Per Share | -$0.79 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 33.97M |
| Total Debt | 10.74M |
| Net Cash | 23.23M |
| Net Cash Per Share | $0.55 |
| Equity (Book Value) | 163.96M |
| Book Value Per Share | 3.86 |
| Working Capital | 83.31M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 3.67M |
| Capital Expenditures | -2.23M |
| Depreciation & Amortization | 22.20M |
| Net Borrowing | -383,000 |
| Free Cash Flow | 1.44M |
| FCF Per Share | $0.03 |
Margins
| Measure | Value |
|---|
| Gross Margin | 55.28% |
| Operating Margin | -6.42% |
| Pretax Margin | -10.07% |
| Profit Margin | -10.12% |
| EBITDA Margin | 0.40% |
| EBIT Margin | -6.42% |
| FCF Margin | 0.44% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.84% |
| Shareholder Yield | n/a |
| Earnings Yield | -6.59% |
| FCF Yield | 0.29% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $19.75 |
| Price Target Difference | 64.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 5.45% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.55 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |